Novartis’ Q3 EPS tumbles 41% to $0.73



Novartis AG revealed on Tuesday that its earnings per share (EPS) in the third trimester of fiscal 2022 slid as much as 41% on an annual basis to stand at $0.73.

Additionally, the multinational pharm…

About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento